Researchers develop nanogel to deliver anti-inflammatory drugs for spinal cord injury by Jen Brogan | Feb 20, 2024 | News | 0 The nanogels, in combination with rolipram, contributed to the recovery of injured tissue Read More
Trials show benefit of ‘on demand’ use of AZ’ asthma inhaler by Selina McKee | May 18, 2018 | News | 0 AstraZeneca has unveiled data from two Phase III trials showing the benefit of using Symbicort Turbuhaler as an anti-inflammatory reliever ‘as needed’ versus two different treatment regimens in patients with mild asthma. Read More